Thyrocare Technologies
THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth
1d
3.0%
1w
8.5%
1m
15.2%
3m
16.1%
6m
21.6%
1y
15.8%
5y
6.5%
10y
10.3%
all
10.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 471 3.0%
468
662
Company Overview

Sales
876 Cr
Growth: 17.9%
Profit after Tax
176 Cr
Growth: 8.1%
Mid Cap
7,501 Cr
P/E: 42.8x
Industry P/E: 48.4x
Fundamentals

Sales (Cr) ₹ 876
Growth 17.9%
EBITDA 32.1%
P/S 8.6x
Dividend 2.1%
P/E 42.8x
Book Value ₹ 40.1
PEG Ratio 2.5x
ROE 26.9%
P/B 12.1x
Shareholding Pattern

Institutions
Arisaig Asia Consumer Fund Limited
6.11 %
Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund
3.57 %
Fundsmith Emerging Equities Trust Plc
1.46 %
Promoters
Dr.A.Velumani
28.02 %
Thyrocare Publications Llp
12.36 %
Thyrocare Properties And Infrastructure Private Imited
9.88 %
A.Sundararaju Huf
4.57 %
Sumathi Infra Project Llp
2.98 %
Others
Bakak Financial Securities
2.84 %
Llp
0.13 %
Increase    Decrease    No change
Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
Investors (110)
Followers (24)